Abstract
Dopamine (DA) agonists, bearing catechol or phenol rings, are endowed with low oral bioavailability and short effect duration. In this report, the synthesis of novel differently substituted 4-(3-pyridyl)-1,2,3,4-tetrahydroisoquinolines and (1,2,3,4-tetrahydroisoquinolin-4-yl)phenylmethanols as potential non phenolic and non catecholic DA receptor ligands is reported. The new compounds, evaluated by binding tests on cerebral striatal membranes, bound to DA receptors with moderate affinity. Anyhow, they may represent a starting point to develop new DA ligands endowed with better pharmacokinetic and metabolic properties.
Keywords: Binding tests, cross-coupling reactions, D1-like receptors, D2-like receptors, dopamine ligands, structure activity relationships, tetrahydroisoquinoline, pharmacokinetic, cerebral striatal membranes, phenylmethanols
Medicinal Chemistry
Title:Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands
Volume: 8 Issue: 4
Author(s): Gianfabio Giorgioni, Dario Ambrosini, Giovanni Filippo Palmieri, Barbara Costa, Antonio Di Stefano and Claudia Martini
Affiliation:
Keywords: Binding tests, cross-coupling reactions, D1-like receptors, D2-like receptors, dopamine ligands, structure activity relationships, tetrahydroisoquinoline, pharmacokinetic, cerebral striatal membranes, phenylmethanols
Abstract: Dopamine (DA) agonists, bearing catechol or phenol rings, are endowed with low oral bioavailability and short effect duration. In this report, the synthesis of novel differently substituted 4-(3-pyridyl)-1,2,3,4-tetrahydroisoquinolines and (1,2,3,4-tetrahydroisoquinolin-4-yl)phenylmethanols as potential non phenolic and non catecholic DA receptor ligands is reported. The new compounds, evaluated by binding tests on cerebral striatal membranes, bound to DA receptors with moderate affinity. Anyhow, they may represent a starting point to develop new DA ligands endowed with better pharmacokinetic and metabolic properties.
Export Options
About this article
Cite this article as:
Giorgioni Gianfabio, Ambrosini Dario, Filippo Palmieri Giovanni, Costa Barbara, Di Stefano Antonio and Martini Claudia, Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands, Medicinal Chemistry 2012; 8 (4) . https://dx.doi.org/10.2174/157340612801216292
DOI https://dx.doi.org/10.2174/157340612801216292 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss
Current Neuropharmacology Cardioprotection Acquired Through Exercise: The Role of Ischemic Preconditioning
Current Cardiology Reviews Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Proteomic Analysis of Alzheimers Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects
Current Alzheimer Research The Role of Cytokine Network in the Pathophysiology of Schizophrenia
Current Psychiatry Reviews Chronic Alcohol Abuse and HIV Disease Progression: Studies with the Non-Human Primate Model
Current HIV Research Nitric Oxide and Dopamine Neurons. Implications for Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract
Current Pharmaceutical Design Exercise and Cognitive-Behavioural Treatment in Fibromyalgia Syndrome
Current Pharmaceutical Design Pathways of Acetylcholine Synthesis, Transport and Release as Targets for Treatment of Adult-Onset Cognitive Dysfunction
Current Medicinal Chemistry Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design The Effects of the 3,4-Methylenedioxymethamphetamine (Ecstasy) in Some Cerebral Areas: Role of the Oxidative Stress
Drug Metabolism Letters Effect of HPMC - E15 LV premium Polymer on Release Profile and Compression Characteristics of Chitosan/ Pectin Colon Targeted Mesalamine Matrix Tablets and in vitro Study on Effect of pH Impact on the Drug Release Profile
Recent Patents on Drug Delivery & Formulation Inhibition of Voltage-Gated Calcium Channels by RGK Proteins
Current Molecular Pharmacology Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
Current Medicinal Chemistry Modifiers of Risk in BRCA1/2 Mutation Carriers
Current Women`s Health Reviews Simultaneous Detection of Dopamine and Serotonin in Real Complex Matrices
Current Analytical Chemistry Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial [Exploring Neural-Immune System Interactions]
Current Immunology Reviews (Discontinued) The Zebrafish Model: Use in Studying Cellular Mechanisms for a Spectrum of Clinical Disease Entities
Current Neurovascular Research